285 related articles for article (PubMed ID: 33511137)
1. Niche Modulation of IGF-1R Signaling: Its Role in Stem Cell Pluripotency, Cancer Reprogramming, and Therapeutic Applications.
Chen PC; Kuo YC; Chuong CM; Huang YH
Front Cell Dev Biol; 2020; 8():625943. PubMed ID: 33511137
[TBL] [Abstract][Full Text] [Related]
2. The role of IGF/IGF-1R signaling in the regulation of cancer stem cells.
Liu F; Ye S; Zhao L; Niu Q
Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38865036
[TBL] [Abstract][Full Text] [Related]
3. Niche Laminin and IGF-1 Additively Coordinate the Maintenance of Oct-4 Through CD49f/IGF-1R-Hif-2α Feedforward Loop in Mouse Germline Stem Cells.
Au HK; Peng SW; Guo CL; Lin CC; Wang YL; Kuo YC; Law TY; Ho HN; Ling TY; Huang YH
Front Cell Dev Biol; 2021; 9():646644. PubMed ID: 34381769
[TBL] [Abstract][Full Text] [Related]
4. IGF-1R Promotes Symmetric Self-Renewal and Migration of Alkaline Phosphatase
Kuo YC; Au HK; Hsu JL; Wang HF; Lee CJ; Peng SW; Lai SC; Wu YC; Ho HN; Huang YH
Stem Cell Reports; 2018 Feb; 10(2):524-537. PubMed ID: 29307582
[TBL] [Abstract][Full Text] [Related]
5. An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population.
Singh RK; Dhadve A; Sakpal A; De A; Ray P
Sci Rep; 2016 Nov; 6():36612. PubMed ID: 27819360
[TBL] [Abstract][Full Text] [Related]
6. IGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy Resistance.
Cox OT; O'Shea S; Tresse E; Bustamante-Garrido M; Kiran-Deevi R; O'Connor R
Front Endocrinol (Lausanne); 2015; 6():106. PubMed ID: 26191041
[TBL] [Abstract][Full Text] [Related]
7. IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer.
Yao C; Su L; Shan J; Zhu C; Liu L; Liu C; Xu Y; Yang Z; Bian X; Shao J; Li J; Lai M; Shen J; Qian C
Stem Cells; 2016 Apr; 34(4):820-31. PubMed ID: 26840943
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies.
Wang H; Cui G; Yu B; Sun M; Yang H
Curr Pharm Des; 2020; 26(17):1979-1993. PubMed ID: 32268862
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
[TBL] [Abstract][Full Text] [Related]
10. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies.
Grassi ES; Ghiandai V; Persani L
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33916320
[TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor type 1 receptor and colorectal neoplasia: insights into invasion.
Allison AS; McIntyre MA; McArdle C; Habib FK
Hum Pathol; 2007 Nov; 38(11):1590-602. PubMed ID: 17651787
[TBL] [Abstract][Full Text] [Related]
13. Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.
Aponte PM; Caicedo A
Stem Cells Int; 2017; 2017():5619472. PubMed ID: 28473858
[TBL] [Abstract][Full Text] [Related]
14. OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.
Rao W; Li H; Song F; Zhang R; Yin Q; Wang Y; Xi Y; Ge H
Carcinogenesis; 2014 Jul; 35(7):1573-81. PubMed ID: 24667688
[TBL] [Abstract][Full Text] [Related]
15. IGF-2/IGF-1R signaling has distinct effects on Sox1, Irx3, and Six3 expressions during ES cell derived-neuroectoderm development in vitro.
Takata N; Sakakura E; Sasai Y
In Vitro Cell Dev Biol Anim; 2016 May; 52(5):607-15. PubMed ID: 26956358
[TBL] [Abstract][Full Text] [Related]
16. IR-A/IGF-1R-mediated signals promote epithelial-mesenchymal transition of endometrial carcinoma cells by activating PI3K/AKT and ERK pathways.
Wang C; Su K; Zhang Y; Zhang W; Zhao Q; Chu D; Guo R
Cancer Biol Ther; 2019; 20(3):295-306. PubMed ID: 30426831
[TBL] [Abstract][Full Text] [Related]
17. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
18. [Research progress on targeting effect and regulating mechanisms of the stemness of cancer stem cells].
Ma HY; He M; Wei MJ
Yao Xue Xue Bao; 2016 Feb; 51(2):189-96. PubMed ID: 29856198
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor-induced mesenchymal-epithelial transition factor activation leads to insulin-like growth factor 1 receptor inhibitor unresponsiveness in gastric cancer cells.
Liu R; Tang W; Han X; Geng R; Wang C; Zhang Z
Oncol Lett; 2018 Nov; 16(5):5983-5991. PubMed ID: 30333869
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.
Sharon C; Baranwal S; Patel NJ; Rodriguez-Agudo D; Pandak WM; Majumdar AP; Krystal G; Patel BB
Oncotarget; 2015 Jun; 6(17):15332-47. PubMed ID: 25895029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
